プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
da aclidiniumbromid hovedsagligt metaboliseres ved kemisk og enzymatisk spaltning i plasma, er det usandsynligt at nedsat leverfunktion ændrer den systemiske exposure.
as aclidinium bromide is metabolised mainly by chemical and enzymatic cleavage in the plasma, hepatic dysfunction is very unlikely to alter its systemic exposure.